Uchino Junji

16PUBLICATIONS
27CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 03, 2023
Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.

Masahiro Iwasaku, Junji Uchino, Kenji Chibana

|Feb 22, 2023
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.

Rei Noguchi, Akihiro Yoshimura, Junji Uchino

|Feb 25, 2022
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer.

Satomi Tanaka, Junji Uchino, Takashi Yokoi

|Feb 23, 2022
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.

Tateaki Naito, Junji Uchino, Toru Kojima

|Sep 12, 2021
Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study.

Kenji Morimoto, Junji Uchino, Takashi Yokoi

|Jul 22, 2021
Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study.

Kenji Morimoto, Junji Uchino, Takashi Yokoi

Pageof 3

Frequent Collaborators

9 joint publications

Tadaaki Yamada

7 joint publications

Takayama Koichi

5 joint publications

Takayuki Takeda

4 joint publications

Akihiro Yoshimura